← Back to Clinical Trials
Recruiting NCT07079995

NCT07079995 Healthy School Recognized Campus: A Hybrid Type 2 Implementation-Effectiveness Trial

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07079995
Status Recruiting
Phase
Sponsor Texas A&M University
Condition Cardiovascular Diseases
Study Type INTERVENTIONAL
Enrollment 900 participants
Start Date 2025-09-01
Primary Completion 2028-06-30

Eligibility & Interventions

Sex All sexes
Min Age 8 Years
Max Age 16 Years
Study Type INTERVENTIONAL
Interventions
Mentoring programWaitlist

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 900 participants in total. It began in 2025-09-01 with a primary completion date of 2028-06-30.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Healthy School Recognized Campus is a Texas A\&M AgriLife Extension initiative that supports the delivery of school-based physical activity and nutrition programs for diverse youth across Texas. The purpose of this study is to conduct a type 2 hybrid implementation-effectiveness, cluster dual randomized controlled trial (DRCT) to assess both Healthy School Recognized Campus (HSRC) and the mentoring program.

Eligibility Criteria

School Inclusion Criteria: * located in Central and East Texas * Public school Student Inclusion Criteria * enrolled in the 4th, 5th, 6th, 7th, 8th, or 9th grade * able to read, speak, and write in English Student Exclusion Criteria: * any motor or cognitive impairments or other health conditions that would prevent them from completing a physical assessment

Contact & Investigator

Central Contact

Jacob Szeszulski

✉ jacob.szeszulski@agnet.tamu.edu

📞 972-952-9202

Principal Investigator

Jacob Szeszulski

PRINCIPAL INVESTIGATOR

Institute for Advancing Health through Agriculture

Frequently Asked Questions

Who can join the NCT07079995 clinical trial?

This trial is open to participants of all sexes, aged 8 Years or older, up to 16 Years, studying Cardiovascular Diseases. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07079995 currently recruiting?

Yes, NCT07079995 is actively recruiting participants. Contact the research team at jacob.szeszulski@agnet.tamu.edu for enrollment information.

Where is the NCT07079995 trial being conducted?

This trial is being conducted at Dallas, United States.

Who is sponsoring the NCT07079995 clinical trial?

NCT07079995 is sponsored by Texas A&M University. The principal investigator is Jacob Szeszulski at Institute for Advancing Health through Agriculture. The trial plans to enroll 900 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology